Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Insulin-secreting non-islet cells are resistant to autoimmune destruction.

Lipes MA, Cooper EM, Skelly R, Rhodes CJ, Boschetti E, Weir GC, Davalli AM.

Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8595-600.

2.
4.

Gene therapy in diabetes mellitus: promises and piffalls.

Welsh N.

Curr Opin Mol Ther. 1999 Aug;1(4):464-70. Review.

PMID:
11713761
5.

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice.

French MB, Allison J, Cram DS, Thomas HE, Dempsey-Collier M, Silva A, Georgiou HM, Kay TW, Harrison LC, Lew AM.

Diabetes. 1997 Jan;46(1):34-9. Erratum in: Diabetes 1997 May;46(5):924.

PMID:
8971078
6.

IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice.

Alba A, Puertas MC, Carrillo J, Planas R, Ampudia R, Pastor X, Bosch F, Pujol-Borrell R, Verdaguer J, Vives-Pi M.

J Immunol. 2004 Dec 1;173(11):6667-75.

7.

Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.

Stephens LA, Kay TW.

Int Immunol. 1995 Dec;7(12):1885-95.

PMID:
8746558
8.

Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.

Mathews CE, Graser RT, Savinov A, Serreze DV, Leiter EH.

Proc Natl Acad Sci U S A. 2001 Jan 2;98(1):235-40.

9.
10.

Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice.

Karges W, Pechhold K, Al Dahouk S, Riegger I, Rief M, Wissmann A, Schirmbeck R, Barth C, Boehm BO.

Diabetes. 2002 Nov;51(11):3237-44.

11.

RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice.

Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J.

J Immunol. 1996 Oct 15;157(8):3688-93.

PMID:
8871671
12.

Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.

Verdaguer J, Yoon JW, Anderson B, Averill N, Utsugi T, Park BJ, Santamaria P.

J Immunol. 1996 Nov 15;157(10):4726-35.

PMID:
8906855
13.

The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice.

Wong FS, Visintin I, Wen L, Granata J, Flavell R, Janeway CA.

J Exp Med. 1998 Jun 15;187(12):1985-93.

14.

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.

16.

Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.

Yoon JW, Jun HS.

Ann N Y Acad Sci. 2001 Apr;928:200-11. Review.

PMID:
11795511
17.

Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.

Sung HH, Juang JH, Lin YC, Kuo CH, Hung JT, Chen A, Chang DM, Chang SY, Hsieh SL, Sytwu HK.

J Exp Med. 2004 Apr 19;199(8):1143-51. Epub 2004 Apr 12.

18.

Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

Silva DG, Petrovsky N, Socha L, Slattery R, Gatenby P, Charlton B.

J Immunol. 2003 May 15;170(10):4996-5002.

19.

Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses.

Dénes B, Yu J, Fodor N, Takátsy Z, Fodor I, Langridge WH.

Mol Biotechnol. 2006 Nov;34(3):317-27.

PMID:
17284779
20.

Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice.

Luo X, Yang H, Kim IS, Saint-Hilaire F, Thomas DA, De BP, Ozkaynak E, Muthukumar T, Hancock WW, Crystal RG, Suthanthiran M.

Transplantation. 2005 May 15;79(9):1091-6.

PMID:
15880049

Supplemental Content

Support Center